Pricing Log in Create free account

Tonix Pharmaceuticals Holding Corp. (TNXP) vs vTv Therapeutics Inc. (VTVT)

Tonix Pharmaceuticals Holding Corp. and vTv Therapeutics Inc. are both Biotechnology companies. Tonix Pharmaceuticals Holding Corp. and vTv Therapeutics Inc. are of similar size ($110.1M and $109.1M). vTv Therapeutics Inc. grew revenue faster over the last twelve months: 654.6% against 196.0%. vTv Therapeutics Inc. has the higher net margin (0.00% vs −548.6%) and the higher return on invested capital (0.00% vs −224.5%). Across the 16 metrics below, vTv Therapeutics Inc. leads on 11 and Tonix Pharmaceuticals Holding Corp. on 5.

Valuation

Metric TNXP VTVT Biotechnology median
P/E n/m n/m 8.50
P/S 3.45 8.71 9.71
P/B 0.45 4.19 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.42 n/m 0.64
EV/Sales (2.35) 6.46 9.21
Earnings yield (219.31%) (2.90%) (33.15%)
Free cash flow yield (157.36%) (5.11%) (25.50%)

Profitability

Metric TNXP VTVT Biotechnology median
Gross margin 83.83% 99.92% 65.16%
Operating margin (568.43%) 0.00% 0.00%
Net margin (548.64%) 0.00% 0.00%
Free cash flow margin (543.29%) 0.00% 0.00%
Return on equity (81.82%) (11.74%) (56.36%)
Return on assets (72.34%) (8.34%) (48.04%)
Return on invested capital (224.52%) 0.00% 0.00%

Growth

Metric TNXP VTVT Biotechnology median
Revenue growth (TTM) 196.02% 654.58% 6.02%
EPS growth (last fiscal year) 91.75% 0.00% 30.26%
Revenue growth, 5-year CAGR — (39.39%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TNXP VTVT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.61 12.48 4.72
Net debt to EBITDA 1.68 2.71 0.96

Dividend

Metric TNXP VTVT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric TNXP VTVT Biotechnology median
Market cap 110.11m 109.09m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack